Trump to sign executive order slashing drug prices up to 80%

Published 12-05-2025, 05:06 am
Updated 12-05-2025, 05:28 am
© Reuters

Investing.com-- President Donald Trump announced on Sunday that he would sign an executive order Monday morning to slash U.S. prescription drug prices by aligning them with the lowest prices paid globally.

Posting on Truth Social, Trump criticized pharmaceutical companies for decades of inflated pricing. He said the U.S. has long paid far more for prescription medicines than peer countries, with some treatments costing five to ten times more despite being manufactured by the same companies in the same facilities.

“Prescription Drug and Pharmaceutical (TADAWUL:2070) prices will be REDUCED, almost immediately, by 30% to 80%,” he wrote.

The order, Trump said, will implement a “Most Favored Nation” policy, compelling U.S. drug prices to match those of countries that pay the least for the same medications.

He claimed the move would save the country “TRILLIONS OF DOLLARS” and reduce healthcare costs for Americans by numbers never even considered.

Trump claimed that drug prices would increase across the globe to facilitate a decrease in U.S. prices, although he did not provide any details on how this would happen.

The U.S. President had in his first term also attempted to launch a drug pricing program based on international prices, although this was blocked by a court. 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.